Filing Details
- Accession Number:
- 0001567619-20-015900
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-24 17:05:40
- Reporting Period:
- 2020-08-20
- Accepted Time:
- 2020-08-24 17:05:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184149 | W Jonathan Ayers | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-20 | 18,000 | $67.85 | 828,467 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-20 | 398 | $380.41 | 828,069 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-20 | 7,445 | $382.08 | 820,624 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-20 | 7,023 | $382.74 | 813,601 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-20 | 2,634 | $383.78 | 810,967 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-20 | 500 | $384.57 | 810,467 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2020-08-20 | 18,000 | $0.00 | 18,000 | $67.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 159,954 | 2026-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 10,000 | Indirect | by Ayers Family Trust |
Footnotes
- Represents the weighted average price of the shares sold ranging from a low of $380.24 to a high of $380.83 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $381.45 to a high of $382.42 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $382.47 to a high of $383.23 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $383.479 to a high of $383.93 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Grant of option to buy shares of Issuer common stock exercisable in five annual installments beginning February 14, 2017.
- Not applicable.
Billionaire Hedge Funds
